| Literature DB >> 20070911 |
Abstract
BACKGROUND: The study aimed at (i) characterizing the mode of transmission of bla(CTX-M) and bla(TEM-1) among extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli strains isolated from infected diabetic foot ulcers, and (ii) identifying the risk factors for "sex-associated multidrug resistant Gram-negative bacterial (MDRGNB)-infection status" of the ulcers.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20070911 PMCID: PMC2821376 DOI: 10.1186/1476-0711-9-2
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Analysis of blaCTX-M-15 markers using bioinformatic approach and clinical profile
| CTX-M-15 positive | D253 | D281 |
|---|---|---|
| ERIC profile | M1 | M1 |
| Class1 integron | + | + |
| + | + | |
| + | + | |
| Sampling date | 8/4/2008 | 14/6/2008 |
| Sex of the patient | Female | Male |
| Accession no. of reference strain used for alignments | ||
| #PDB ID of the template retrieved for modeling | ||
| Cefotaxime MIC of the strain (mg/L) | 256 | 64 |
| Ceftazidime MIC of the strain (mg/L) | 32 | 32 |
| *E-total (Kj/mol) | -221.51 | -168.17 |
| *E-shape (Kj/mol) | -208 | -147.5 |
| *E-force (Kj/mol) | -13.51 | -20.67 |
| Genbank accession numbers (This study) | ||
#PDB = Protein Data Bank
*E = Binding energy with cefotaxime
Figure 1Distribution of multidrug resistant Gram-negative bacteria obtained from infected diabetic foot ulcers divided into 2-month periods from April 2007 to November 2008.
Transconjugation frequencies, resistance markers transferred to recipient strains and MICs of antibiotics used against blaCTX-M-15 positive strains of E. coli
| Name of the strain | D253 | D281 |
|---|---|---|
| 0 | 0 | |
| Gentamicin (G) | 128 | 64 |
| Tobramycin (Tb) | 64 | 32 |
| Kanamycin (Ka) | 64 | 128 |
| Amikacin (Ak) | 32 | 32 |
| Streptomycin (St) | 64 | 64 |
| Cefazolin (Cz) | >256 | >256 |
| Ceftazidime (Ca) | 32 | 32 |
| Cefotaxime (Ce) | 256 | 64 |
| Ceftriaxone (Ci) | 256 | 512 |
| Cefepime (Cpm) | 64 | 64 |
| Ciprofloxacin (Cf) | 64 | 64 |
| Norfloxacin (Nx) | 64 | 32 |
| Piperacillin (Pc) | >256 | 512 |
| Amoxyclav (Ac) | 4 | 2 |
| Tetracycline (T) | 256 | 512 |
| 3 | 3 | |
| G, Tb, Ka, St, Ch, Cz, Cu, Ca, T, Ce, Ci, Cpm, Cf, Nx, Pc | G, Tb, Ka, St, Ch, Cz, Cu, Ca, T, Ce, Ci, Cpm, Cf, Nx, Pc | |
| Ca, Ce, Ci, T | Ca, Ce, Ci, Cf | |
| 1.7 × 102 | 2.1 × 102 | |
| 107 | 107 | |
| 1.7 × 10-5 | 2.1 × 10-5 | |
Figure 2ERIC-profiles of extended-spectrum β-lactamase producing bacteria isolated from infected foot ulcers of diabetic patients. 'M' stands for marker (the first lane of each figure).
Figure 3(a) CTX-M-15 enzyme modeled from the FJ997866] of . The active site Ω-loop, the SDN loop and the KTG motif are labeled. A = 91.5%, B = 7.8%, C = 0.7%, D = 0.0%, where 'A', 'B', 'C' and 'D' stand for percent amino acid residues in most favored, additional allowed, generously allowed and disallowed regions of the Ramachandran plot respectively. The z-score for the modeled structure was equal to 0.027. (b) Amino acid residues crucial to the interaction between cefotaxime and CTX-M-15.